Faro Technologies (NASDAQ: FARO) and Abaxis (NASDAQ:ABAX) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, dividends, profitability and analyst recommendations.
This is a breakdown of recent recommendations and price targets for Faro Technologies and Abaxis, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
This table compares Faro Technologies and Abaxis’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Valuation and Earnings
This table compares Faro Technologies and Abaxis’ gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Faro Technologies||$360.92 million||2.54||-$14.51 million||$0.29||186.72|
|Abaxis||$244.70 million||7.70||$27.17 million||$1.29||64.35|
Abaxis has lower revenue, but higher earnings than Faro Technologies. Abaxis is trading at a lower price-to-earnings ratio than Faro Technologies, indicating that it is currently the more affordable of the two stocks.
Abaxis pays an annual dividend of $0.64 per share and has a dividend yield of 0.8%. Faro Technologies does not pay a dividend. Abaxis pays out 49.6% of its earnings in the form of a dividend.
Institutional and Insider Ownership
90.7% of Faro Technologies shares are owned by institutional investors. Comparatively, 94.8% of Abaxis shares are owned by institutional investors. 3.1% of Faro Technologies shares are owned by company insiders. Comparatively, 4.3% of Abaxis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Volatility and Risk
Faro Technologies has a beta of 1.48, indicating that its stock price is 48% more volatile than the S&P 500. Comparatively, Abaxis has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500.
Abaxis beats Faro Technologies on 9 of the 16 factors compared between the two stocks.
Faro Technologies Company Profile
FARO Technologies, Inc. designs, develops, manufactures, markets, and supports software driven, three-dimensional (3D) measurement, imaging, and realization systems. The company offers FaroArm, a combination of six or seven-axis, articulated measurement arm, a computer, and CAM2 software programs; and FARO ScanArm, a FaroArm equipped with a hard probe and non-contact laser line probe to measure products. It also provides FARO Gage, a combination of an articulated arm device with a computer and software; FARO Laser Tracker that combines a portable laser measurement tool, a computer, and CAM2 software programs; FARO Cobalt Array Imager, a metrology-grade structured light imager; FARO Tracer, which projects a laser line onto a surface or object; and FARO Focus laser scanner to measure and collect a cloud of data points. In addition, the company offers FARO Scanner Freestyle3DX, a handheld scanner that documents rooms, structures, and objects in 3D, as well as creates high-definition point clouds; and FARO Software, a proprietary computer-aided design-based measurement and laser scanner software. FARO Technologies, Inc. offers its products for manufacturing, industrial, architecture, surveying, building information modeling, construction, public safety, cultural heritage, and other applications. The company sells its products in Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Malaysia, Mexico, the Netherlands, Poland, Portugal, Singapore, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, the United Kingdom, and the United States. FARO Technologies, Inc. was founded in 1981 and is headquartered in Lake Mary, Florida.
Abaxis Company Profile
Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide rapid blood constituent measurements for clinicians worldwide. It operates in two segments, Medical Market and Veterinary Market. The company offers Piccolo chemistry analyzers with rapid blood constituent measurements for use in human patient care; and Piccolo profiles that are single-use medical reagents. It also provides VetScan VS2, a chemistry, electrolyte, immunoassay, and blood gas analyzer delivering results from a sample of whole blood, serum, or plasma; VetScan profiles, which are packaged as single-use plastic veterinary reagent discs; and VetScan HM5, VetScan HM2, VetScan HMII, and VetScan HMT hematology instruments, as well as reagent kits for veterinary applications. In addition, the company offers VetScan VSpro that assists the diagnosis and evaluation of suspected bleeding disorders, toxicity/poisoning, disseminated intravascular coagulation evaluation, hepatic disease, monitoring therapy, and disease progression states; VetScan VSpro coagulation test to evaluate prothrombin and the activated partial thromboplastin times; VetScan VSpro fibrinogen test for in-vitro determination of fibrinogen levels in equine platelet poor plasma from a citrated stabilized whole blood sample; and i-STAT that delivers blood gas, electrolyte, chemistry, and hematology results. Further, it provides VetScan rapid tests for the detection of various diseases, as well as sells products developed through its patented Orbos discrete lyophilization process to companies for other applications. The company sells its products through direct sales force and independent distributors. Abaxis, Inc. was founded in 1989 and is headquartered in Union City, California.
Receive News & Ratings for Faro Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faro Technologies and related companies with MarketBeat.com's FREE daily email newsletter.